Marijuana for the treatment of seizure disorders

Emily Knezevich, Yunuo Wu

Research output: Contribution to specialist publicationArticle

1 Citation (Scopus)

Abstract

Cannabis, the substance more commonly known as marijuana, has gained interest in recent years for its potential use as an antiepileptic agent. The two main components of marijuana are delta-9-tetrahydrocannabinol, which has had mixed effects in epilepsy, and cannabidiol, which has shown more consistent anticonvulsant effects. Data supporting the use of marijuana for this purpose are limited, as the majority of clinical trials were conducted before 1990. There are case reports showing promising results; however, the data are inconsistent and cannot be generalized. The legal issues surrounding marijuana in the United States also may limit the use of this substance as an antiepileptic.

Original languageEnglish
Pages24-28
Number of pages5
Volume40
No1
Specialist publicationU.S. Pharmacist
StatePublished - Jan 1 2015

Fingerprint

Medical Marijuana
Cannabis
Epilepsy
Anticonvulsants
Cannabidiol
Dronabinol
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Pharmacology
  • Pharmacy

Cite this

Marijuana for the treatment of seizure disorders. / Knezevich, Emily; Wu, Yunuo.

In: U.S. Pharmacist, Vol. 40, No. 1, 01.01.2015, p. 24-28.

Research output: Contribution to specialist publicationArticle

Knezevich, Emily ; Wu, Yunuo. / Marijuana for the treatment of seizure disorders. In: U.S. Pharmacist. 2015 ; Vol. 40, No. 1. pp. 24-28.
@misc{fd472c750cca4b4b87bf1add4fdd9699,
title = "Marijuana for the treatment of seizure disorders",
abstract = "Cannabis, the substance more commonly known as marijuana, has gained interest in recent years for its potential use as an antiepileptic agent. The two main components of marijuana are delta-9-tetrahydrocannabinol, which has had mixed effects in epilepsy, and cannabidiol, which has shown more consistent anticonvulsant effects. Data supporting the use of marijuana for this purpose are limited, as the majority of clinical trials were conducted before 1990. There are case reports showing promising results; however, the data are inconsistent and cannot be generalized. The legal issues surrounding marijuana in the United States also may limit the use of this substance as an antiepileptic.",
author = "Emily Knezevich and Yunuo Wu",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "24--28",
journal = "U.S. Pharmacist",
issn = "0148-4818",
publisher = "Jobson Publishing Corporation",

}

TY - GEN

T1 - Marijuana for the treatment of seizure disorders

AU - Knezevich, Emily

AU - Wu, Yunuo

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Cannabis, the substance more commonly known as marijuana, has gained interest in recent years for its potential use as an antiepileptic agent. The two main components of marijuana are delta-9-tetrahydrocannabinol, which has had mixed effects in epilepsy, and cannabidiol, which has shown more consistent anticonvulsant effects. Data supporting the use of marijuana for this purpose are limited, as the majority of clinical trials were conducted before 1990. There are case reports showing promising results; however, the data are inconsistent and cannot be generalized. The legal issues surrounding marijuana in the United States also may limit the use of this substance as an antiepileptic.

AB - Cannabis, the substance more commonly known as marijuana, has gained interest in recent years for its potential use as an antiepileptic agent. The two main components of marijuana are delta-9-tetrahydrocannabinol, which has had mixed effects in epilepsy, and cannabidiol, which has shown more consistent anticonvulsant effects. Data supporting the use of marijuana for this purpose are limited, as the majority of clinical trials were conducted before 1990. There are case reports showing promising results; however, the data are inconsistent and cannot be generalized. The legal issues surrounding marijuana in the United States also may limit the use of this substance as an antiepileptic.

UR - http://www.scopus.com/inward/record.url?scp=84921881882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921881882&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84921881882

VL - 40

SP - 24

EP - 28

JO - U.S. Pharmacist

JF - U.S. Pharmacist

SN - 0148-4818

ER -